556 related articles for article (PubMed ID: 34159616)
21. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.
Zhao H; Lu L; Peng Z; Chen LL; Meng X; Zhang C; Ip JD; Chan WM; Chu AW; Chan KH; Jin DY; Chen H; Yuen KY; To KK
Emerg Microbes Infect; 2022 Dec; 11(1):277-283. PubMed ID: 34951565
[TBL] [Abstract][Full Text] [Related]
22. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.
Shirato K; Kawase M; Matsuyama S
J Virol; 2013 Dec; 87(23):12552-61. PubMed ID: 24027332
[TBL] [Abstract][Full Text] [Related]
23. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
[TBL] [Abstract][Full Text] [Related]
24. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Matsuyama S; Nao N; Shirato K; Kawase M; Saito S; Takayama I; Nagata N; Sekizuka T; Katoh H; Kato F; Sakata M; Tahara M; Kutsuna S; Ohmagari N; Kuroda M; Suzuki T; Kageyama T; Takeda M
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7001-7003. PubMed ID: 32165541
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
[TBL] [Abstract][Full Text] [Related]
26. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
Sasaki M; Uemura K; Sato A; Toba S; Sanaki T; Maenaka K; Hall WW; Orba Y; Sawa H
PLoS Pathog; 2021 Jan; 17(1):e1009233. PubMed ID: 33476327
[TBL] [Abstract][Full Text] [Related]
28. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
Abbasi AZ; Kiyani DA; Hamid SM; Saalim M; Fahim A; Jalal N
J Med Virol; 2021 Jul; 93(7):4205-4218. PubMed ID: 33638460
[TBL] [Abstract][Full Text] [Related]
29. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
Hoffmann M; Hofmann-Winkler H; Smith JC; Krüger N; Arora P; Sørensen LK; Søgaard OS; Hasselstrøm JB; Winkler M; Hempel T; Raich L; Olsson S; Danov O; Jonigk D; Yamazoe T; Yamatsuta K; Mizuno H; Ludwig S; Noé F; Kjolby M; Braun A; Sheltzer JM; Pöhlmann S
EBioMedicine; 2021 Mar; 65():103255. PubMed ID: 33676899
[TBL] [Abstract][Full Text] [Related]
30. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
[TBL] [Abstract][Full Text] [Related]
31. Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells.
Almeida-da-Silva CLC; Matshik Dakafay H; Liu K; Ojcius DM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299289
[TBL] [Abstract][Full Text] [Related]
32. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
33.
Huang ST; Chen Y; Chang WC; Chen HF; Lai HC; Lin YC; Wang WJ; Wang YC; Yang CS; Wang SC; Hung MC
Viruses; 2021 May; 13(5):. PubMed ID: 34063247
[TBL] [Abstract][Full Text] [Related]
34. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
Muus C; Luecken MD; Eraslan G; Sikkema L; Waghray A; Heimberg G; Kobayashi Y; Vaishnav ED; Subramanian A; Smillie C; Jagadeesh KA; Duong ET; Fiskin E; Torlai Triglia E; Ansari M; Cai P; Lin B; Buchanan J; Chen S; Shu J; Haber AL; Chung H; Montoro DT; Adams T; Aliee H; Allon SJ; Andrusivova Z; Angelidis I; Ashenberg O; Bassler K; Bécavin C; Benhar I; Bergenstråhle J; Bergenstråhle L; Bolt L; Braun E; Bui LT; Callori S; Chaffin M; Chichelnitskiy E; Chiou J; Conlon TM; Cuoco MS; Cuomo ASE; Deprez M; Duclos G; Fine D; Fischer DS; Ghazanfar S; Gillich A; Giotti B; Gould J; Guo M; Gutierrez AJ; Habermann AC; Harvey T; He P; Hou X; Hu L; Hu Y; Jaiswal A; Ji L; Jiang P; Kapellos TS; Kuo CS; Larsson L; Leney-Greene MA; Lim K; Litviňuková M; Ludwig LS; Lukassen S; Luo W; Maatz H; Madissoon E; Mamanova L; Manakongtreecheep K; Leroy S; Mayr CH; Mbano IM; McAdams AM; Nabhan AN; Nyquist SK; Penland L; Poirion OB; Poli S; Qi C; Queen R; Reichart D; Rosas I; Schupp JC; Shea CV; Shi X; Sinha R; Sit RV; Slowikowski K; Slyper M; Smith NP; Sountoulidis A; Strunz M; Sullivan TB; Sun D; Talavera-López C; Tan P; Tantivit J; Travaglini KJ; Tucker NR; Vernon KA; Wadsworth MH; Waldman J; Wang X; Xu K; Yan W; Zhao W; Ziegler CGK; ;
Nat Med; 2021 Mar; 27(3):546-559. PubMed ID: 33654293
[TBL] [Abstract][Full Text] [Related]
35. Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2.
Li Y; Wang K; Sun H; Wu S; Wang H; Shi Y; Li X; Yan H; Yang G; Wu M; Li Y; Ding X; Si S; Jiang J; Du Y; Li Y; Hong B
Antiviral Res; 2023 Jun; 214():105606. PubMed ID: 37076089
[TBL] [Abstract][Full Text] [Related]
36. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
Shirato K; Kanou K; Kawase M; Matsuyama S
J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
[TBL] [Abstract][Full Text] [Related]
37. A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.
Chen Y; Lear TB; Evankovich JW; Larsen MB; Lin B; Alfaras I; Kennerdell JR; Salminen L; Camarco DP; Lockwood KC; Tuncer F; Liu J; Myerburg MM; McDyer JF; Liu Y; Finkel T; Chen BB
Nat Commun; 2021 Jun; 12(1):3907. PubMed ID: 34162861
[TBL] [Abstract][Full Text] [Related]
38. Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro.
Unal MA; Bitirim CV; Summak GY; Bereketoglu S; Cevher Zeytin I; Besbinar O; Gurcan C; Aydos D; Goksoy E; Kocakaya E; Eran Z; Murat M; Demir N; Aksoy Ozer ZB; Somers J; Demir E; Nazir H; Ozkan SA; Ozkul A; Azap A; Yilmazer A; Akcali KC
Can J Physiol Pharmacol; 2021 May; 99(5):449-460. PubMed ID: 33689451
[TBL] [Abstract][Full Text] [Related]
39. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
Boon ACM; Bricker TL; Fritch EJ; Leist SR; Gully K; Baric RS; Graham RL; Troan BV; Mahoney M; Janetka JW
J Virol; 2024 May; 98(5):e0190323. PubMed ID: 38593045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
